To condition or not condition? Analysing 'change' in longitudinal randomised controlled trials

BMJ Open

Volumn 6, Issue 12, 2016, Pages

  Coffman, Cynthia J ^a,b   Edelman, David ^a,b   Woolson, Robert F ^a,b  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ANCOVA; Constrained longitudinal data analysis; Longitudinal RCT

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN;

ARTICLE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); ANALYSIS OF VARIANCE; BLOOD; DIABETES MELLITUS; DIABETIC COMPLICATION; DIET RESTRICTION; FEMALE; MALE; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; CHOLESTEROL, LDL; DIABETES COMPLICATIONS; DIABETES MELLITUS; FASTING; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS, LDL; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 85008517764     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-013096     Document Type: Article

References (19)

1. Edelman D, Fredrickson SK, Melnyk SD, et al. Medical clinics versus usual care for patients with both diabetes and hypertension: a randomized trial. Ann Intern Med 2010;152:689-96.
2. Lord FM. A paradox in the interpretation of group comparisons. Psychol Bull 1967;68:304-5.
3. Frison L, Pocock SJ. Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. Stat Med 1992;11:1685-704.
4. Senn S. Change from baseline and analysis of covariance revisited. Stat Med 2006;25:4334-44.
5. Liang KY, Zeger SL. Longitudinal data analysis of continuous and discrete responses for pre-post designs. Sankhya - The Indian Journal of Statistics, Series B 2000;62:134-48.
6. Fitzmaurice GM, Laird NM, Ware JH. Applied longitudinal analysis. Hoboken, NJ: Wiley, 2011.
7. Crager MR. Analysis of covariance in parallel-group clinical trials with pretreatment baselines. Biometrics 1987;43:895-901.
8. Vickers AJ, Altman DG. Statistics notes: analysing controlled trials with baseline and follow up measurements. BMJ 2001;323:1123-4.
9. Fleming TR. Addressing missing data in clinical trials. Ann Intern Med 2011;154:113-17.
10. Mallinckrod CH, Lane PW, Schnell D, et al. Recommendations for the primary analysis of continuous endpoints in longitudinal clinical trials. Drug Info J 2008;42:303-19.
11. Liu GF, Lu K, Mogg R, et al. Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials? Stat Med 2009;28:2509-30.
12. Lu K, Mehrotra DV, Liu G. Sample size determination for constrained longitudinal data analysis. Stat Med 2009;28:679-99.
13. Kenward MG, White IR, Carpenter JR. Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials? by G. F. Liu, K. Lu, R. Mogg, M. Mallick and D. V. Mehrotra, Statistics in Medicine 2009;28:2509-2530. Stat Med 2010;29:1455-6.
14. Crowley MJ, Melnyk SD, Ostroff JL, et al. Can group medical clinics improve lipid management in diabetes? Am J Med 2014;127:145-51.
15. Verbeke G, Molenberghs G. Linear mixed models for longitudinal data. New York: Springer, 2000.
16. Little RJA, Rubin DB. Statistical analysis with missing data. Wiley, 2002.
17. Schafer JL. Analysis of incomplete multivariate data. London: Chapman & Hall, 1997.
18. Olsen MK, Stechuchak KM, Edinger JD, et al. Move over LOCF: principled methods for handling missing data in sleep disorder trials. Sleep Med 2012;13:123-32.
19. Egbewale BE, Lewis M, Sim J. Bias, precision and statistical power of analysis of covariance in the analysis of randomized trials with baseline imbalance: a simulation study. BMC Med Res Methodol 2014;14:49.